HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu Du Selected Research

Type 2 Diabetes Mellitus (MODY)

12/2023Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA.
11/2022LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial.
1/2021Metformin alleviates choline diet-induced TMAO elevation in C57BL/6J mice by influencing gut-microbiota composition and functionality.
4/2018Platelet Distribution Width on Admission Predicts In-Stent Restenosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Treated with Percutaneous Coronary Intervention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu Du Research Topics

Disease

55Neoplasms (Cancer)
05/2024 - 03/2012
14Cataract (Cataracts)
03/2023 - 07/2017
12Infections
04/2024 - 12/2014
12Hypoxia (Hypoxemia)
12/2023 - 01/2016
11Inflammation (Inflammations)
02/2023 - 01/2018
10Pain (Aches)
05/2024 - 04/2013
10Breast Neoplasms (Breast Cancer)
02/2024 - 01/2018
10Atherosclerosis
01/2023 - 06/2012
9Cardiovascular Diseases (Cardiovascular Disease)
08/2023 - 01/2015
8Obesity
01/2024 - 06/2016
8Endometriosis
10/2020 - 03/2016
7Hepatocellular Carcinoma (Hepatoma)
03/2024 - 04/2013
6Lung Neoplasms (Lung Cancer)
05/2024 - 05/2015
6Squamous Cell Carcinoma of Head and Neck
01/2022 - 01/2014
6Coronary Artery Disease (Coronary Atherosclerosis)
03/2020 - 08/2017
5Carcinogenesis
03/2024 - 01/2018
5Melanoma (Melanoma, Malignant)
01/2024 - 05/2021
5Lymphoma (Lymphomas)
01/2023 - 09/2013
5Insulin Resistance
01/2022 - 02/2015
5Carcinoma (Carcinomatosis)
01/2022 - 01/2017
5Ischemia
12/2021 - 09/2012
5Wounds and Injuries (Trauma)
01/2021 - 01/2004
5Poisoning
01/2021 - 11/2009
4Myopia
05/2024 - 01/2021
4Heart Failure
04/2024 - 07/2014
4Type 2 Diabetes Mellitus (MODY)
12/2023 - 04/2018
4Body Weight (Weight, Body)
08/2023 - 01/2020
4COVID-19
01/2023 - 11/2020
4Hemorrhage
09/2022 - 06/2017
4Neoplasm Metastasis (Metastasis)
01/2022 - 02/2016
3Liver Neoplasms (Liver Cancer)
02/2024 - 04/2013
3Shock
08/2023 - 01/2018
3Reperfusion Injury
11/2022 - 10/2019
3Prostatic Neoplasms (Prostate Cancer)
01/2022 - 07/2014
3Neuroinflammatory Diseases
09/2021 - 12/2019
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2021 - 10/2018
3Hypokalemia
01/2021 - 05/2018
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2020 - 01/2020
3Pathologic Constriction (Stenosis)
01/2020 - 06/2016
3ST Elevation Myocardial Infarction
10/2019 - 10/2019
3Head and Neck Neoplasms (Head and Neck Cancer)
04/2014 - 07/2013
2Heart Arrest (Cardiac Arrest)
04/2024 - 01/2018
2Pathologic Processes
03/2024 - 01/2022
2Skin Diseases (Skin Disease)
02/2024 - 01/2022
2Vomiting
12/2023 - 01/2023
2Hyperplasia
12/2023 - 03/2019
2Nausea
12/2023 - 01/2023

Drug/Important Bio-Agent (IBA)

28Proteins (Proteins, Gene)FDA Link
05/2024 - 06/2012
19Biomarkers (Surrogate Marker)IBA
01/2024 - 07/2013
10Glucose (Dextrose)FDA LinkGeneric
09/2023 - 02/2015
9Messenger RNA (mRNA)IBA
01/2022 - 01/2015
8LipidsIBA
02/2024 - 12/2009
6Circular RNAIBA
01/2024 - 10/2020
6CytokinesIBA
10/2023 - 01/2018
5ErbB Receptors (EGF Receptor)IBA
05/2024 - 04/2014
5DNA (Deoxyribonucleic Acid)IBA
02/2023 - 02/2003
5Indicators and Reagents (Reagents)IBA
12/2022 - 01/2017
5Therapeutic UsesIBA
12/2022 - 09/2019
5CholesterolIBA
04/2020 - 12/2009
4retatrutideIBA
12/2023 - 01/2022
4AntioxidantsIBA
01/2023 - 10/2018
4Phosphotransferases (Kinase)IBA
01/2023 - 01/2019
4MicroRNAs (MicroRNA)IBA
11/2022 - 01/2015
4AdipokinesIBA
01/2022 - 06/2016
4Estrogens (Estrogen)FDA Link
01/2021 - 01/2017
4WD repeat containing planar cell polarity effectorIBA
03/2020 - 10/2017
4Analgesics (Analgesic Drugs)IBA
11/2019 - 04/2013
4Caspase 3 (Caspase-3)IBA
01/2019 - 01/2004
3RNA (Ribonucleic Acid)IBA
03/2024 - 10/2019
3CollagenIBA
01/2024 - 01/2021
3Interleukin-17 (Interleukin 17)IBA
11/2023 - 01/2021
3ConnexinsIBA
09/2023 - 08/2021
3Reactive Oxygen Species (Oxygen Radicals)IBA
03/2023 - 12/2021
3Antiviral Agents (Antivirals)IBA
01/2023 - 07/2020
3Proteolysis Targeting ChimeraIBA
12/2022 - 01/2022
3Crystallins (Crystallin)IBA
09/2022 - 01/2018
3Interleukin-6 (Interleukin 6)IBA
12/2021 - 11/2020
3AcidsIBA
01/2021 - 01/2020
3CateninsIBA
12/2019 - 04/2013
3Long Noncoding RNAIBA
08/2019 - 01/2019
3Insulin (Novolin)FDA Link
01/2018 - 02/2015
3salicylhydroxamic acid (SHAM)IBA
05/2013 - 09/2012
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2024 - 11/2023
2Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2024 - 01/2023
2Butyrates (Butyrate)IBA
01/2024 - 01/2020
2dulaglutideIBA
12/2023 - 11/2022
2Glucagon Receptors (Glucagon Receptor)IBA
12/2023 - 11/2022
2Glucagon-Like Peptide 1 (GLP 1)IBA
12/2023 - 11/2022
2LigandsIBA
11/2023 - 07/2014

Therapy/Procedure

35Therapeutics
05/2024 - 12/2012
6Radiotherapy
12/2023 - 09/2013
5Drug Therapy (Chemotherapy)
05/2024 - 09/2013
5Immunotherapy
11/2023 - 01/2019
4Intraocular Lenses (Intraocular Lens)
01/2023 - 10/2019
4Slit Lamp
01/2020 - 06/2017
4Percutaneous Coronary Intervention
10/2019 - 04/2018
2Injections
05/2024 - 01/2023
2Length of Stay
04/2024 - 01/2024
2Transplantation
02/2024 - 11/2023
2Neoadjuvant Therapy
01/2024 - 12/2022